🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Norwegian Microbiota Study in Anorexia Nervosa

Recruitingn/aAges 16 Years - 50 YearsFemaleNorwegian University of Life Sciences
NCT06144905 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Anorexia nervosa (AN) is a serious mental disorder occurring mainly in women. AN is characterized by severely restricted food-intake and subsequent low weight. The disease burden for the individual is high with medical complications and psychiatric comorbidities. Despite decades of research, there are large gaps in the understanding of the biological aspects of AN and lack of effective interventions. Current clinical treatment is associated with gastrointestinal problems, high rates of relapse and poor outcome causing long-term sickness absence and disability. During the COVID19 pandemic the prevalence and severity of AN has spiked. Therefore, there is great need of novel strategies for AN treatment, that can be easily implemented in the clinic without adding complexity to the standard care of treatment. During the resent years it has been proposed that mental disorders might be treated

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria AN group 1. Sex: Female 2. Age: 16-50 years 3. BMI: \<18.5 kg/m2 4. fulfilling ICD-10 criteria for AN 5. currently referred to specialized inpatient nutritional treatment for AN 6. able to understand the Norwegian questionnaires. Exclusion Criteria AND group: 1. history of inflammatory bowel disease, celiac disease, or GI tract surgery; 2. treatment with oral antibiotics the past two months 3. high intake of probiotic supplements over the past two months. Inclusion criteria control group 1. Sex: Female 2. Age: 16-50 years 3. BMI: \>= 18.5 \& \< 27 4. able to understand the Norwegian questionnaires. Exclusion Criteria AND group: 1. history of inflammatory bowel disease, celiac disease, or GI tract surgery; 2. treatment with oral antibiotics the past two months 3. high intake of probiotic supplements over the past two months.
💊

What it tests

  • standard care treatment program
📍

Where

1 site
Norwegian University of Life Sciences
Ås, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy